NADPH Oxidase-Mediated Triggering of Inflammasome Activation in Mouse Podocytes and Glomeruli During Hyperhomocysteinemia

Abstract

Aim: Our previous studies have shown that NOD-like receptor protein (NALP3) inflammasome activation is importantly involved in podocyte dysfunction and glomerular sclerosis induced by hyperhomocysteinemia (hHcys). The present study was designed to test whether nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-mediated redox signaling contributes to homocysteine (Hcys)-induced activation of NALP3 inflammasomes, an intracellular inflammatory machinery in podocytes in vitro and in vivo. Results: In vitro confocal microscopy and size-exclusion chromatography revealed that upon NADPH oxidase inhibition by gp91 phox siRNA, gp91ds-tat peptide, diphenyleneiodonium, or apocynin, aggregation of inflammasome proteins NALP3, apoptosis-associated speck-like protein (ASC), and caspase-1 was significantly attenuated in mouse podocytes. This NADPH oxidase inhibition also resulted in diminished Hcys-induced inflammasome activation, evidenced by reduced caspase-1 activity and interleukin-1b production. Similar findings were observed in vivo where gp91phox -/ -mice and mice receiving a gp91ds-tat treatment exhibited markedly reduced inflammasome formation and activation. Further, in vivo NADPH oxidase inhibition protected the glomeruli and podocytes from hHcys-induced injury as shown by attenuated proteinuria, albuminuria, and glomerular sclerotic changes. This might be attributed to the fact that gp91phox -/ -and gp91ds-tat-treated mice had abolished infiltration of macrophages and T-cells into the glomeruli during hHcys. Innovation: Our study for the first time links NADPH oxidase to the formation and activation of NALP3 inflammasomes in podocytes. Conclusion: Hcys-induced NADPH oxidase activation is importantly involved in the switching on of NALP3 inflammasomes within podocytes, which leads to the downstream recruitment of immune cells, ultimately resulting in glomerular injury and sclerosis. Antioxid. Redox Signal. 18, 1537-1548.

Protein Kinase Cζ Inhibitor Promotes Resolution of Bleomycin-Induced Acute Lung Injury

“…These data strongly suggest that NOX2 inhibition during neonatal sepsis attenuates lung inflammation, tissue damage, and alveolar remodeling. Although the use of gp91phox ds-tat in an animal model of sepsis is new, these data are consistent with other reports that indicate NOX2-mediated injury in hypertension, diabetes, and inflammasome activation is inhibited with gp91phox ds-tat (31,54,55). We used gp91phox ds-tat before intraperitoneal LPS injection to generate proof-of-principle data as a potential therapeutic agent in sepsis.…”

Hemolysis-induced lethality involves inflammasome activation by heme

“…Similar results were obtained with cells from patients with CGD carrying mutations in the CYBB (the NOX2 gene) or with macrophages from gp91phox −/− (44,54). A recent study, however, demonstrated the requirement of NOX2 for activation of NLRP3 by homocysteine in podocytes, both in vitro and in vivo, contributing to kidney inflammation and tissue damage (55). Inhibition of NADPH oxidase activity by apocynin and the genetic deficiency of gp91phox −/− on primary BMMs abrogated the activation of inflammasome by heme.…”

Microglial/Macrophage Polarization Dynamics following Traumatic Brain Injury

“…Dosing of gp91ds-tat was based on reported therapeutic effects in mice. 21 The ds-tat scrambled-and gp91ds-tat-treated CCI mice were anesthetized (100 mg/kg sodium pentobarbital, i.p.) at 7 d post-injury and transcardially perfused with ice-cold 0.9% saline (100 mL), followed by 300 mL of 4% paraformaldehyde.…”